Outcome for Patients with Triple-Negative Breast Cancer Is Not Dependent on Race/Ethnicity

Table 4

Comparison of clinical outcomes for patients with triple-receptor negative breast cancer.

	Overall survival (%)	Disease free survival (%)
Chu (FWCC)	75	60; 66(AA), 50 (C)
Haffty	80	72
Bauer	77	—
Kyndi	50 (high-risk cohort)	—
Lund	59.6	30.8
Dawood	71 (3-yr OS)	68 (AA), 62 (C)

FWCC: Feist-Weiller Cancer Center, AA: African-american, and C: Caucasian.